A randomized phase II study of TS-1+Cisplatin versus Vinorelbine+Cisplatin,with thoracic radiotherapy for locally advanced non-small cell lung cancer.
Latest Information Update: 26 Sep 2018
At a glance
- Drugs Cisplatin (Primary) ; Gimeracil/oteracil/tegafur (Primary) ; Vinorelbine (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 18 Sep 2018 Status changed from active, no longer recruiting to completed.
- 12 Sep 2018 Primary endpoint (2 year OS rate) has been met, as per the results published in the British Journal of Cancer
- 12 Sep 2018 Results published in the British Journal of Cancer